Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the Cyto-Mine® platform has been selected by FairJourney Biologics, a world leading end-to-end antibody partner, providing integrated services across antibody discovery, engineering, and production, to expand its cell line development capabilities.

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome – Biotech Investments

Issuer: Immunic AG / Key word(s): Study 04.09.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Announces First

September 5, 2024

Dog Bite Deaths Rise, First Lady Tests Negative, Parents Targeted in Fentanyl Deaths

Note that some links may require registration or subscription. Deaths from being bitten or struck by a dog are on the rise, according to the

September 9, 2023

Cytokinetics looks to take on BMS’ Camzyos in hypertrophic cardiomyopathy

Cytokinetics’s aficamten is a myosin inhibitor that reduces the interaction between actin and myosin to prevent muscle hypercontractility. Image Credit: Michael Vi / Shutterstock. Cytokinetics

May 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.